What do systematic reviews say?

Intravenous vs intraosseous route

Intravenous may leads to higher insertion failures compared with intraosseous route (low certainty).

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  RR 3.89 [2.39, 6.33]
  2 studies · 242 participants
  Low

Intravenous vs subcutaneous route

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 4 participants
  Low

Intravenous vs intraosseous route

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 342 participants
  Moderate

Intravenous vs intraosseous route

Intravenous showed no clear difference in dislodgement of device during infusion compared with intraosseous route (low certainty).

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  RR 0.53 [0.18, 1.55]
  1 study · 182 participants
  Low

Intravenous vs intraosseous route

The review found no eligible studies for this question.

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intravenous vs intraosseous route

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 182 participants
  Moderate

Intravenous vs subcutaneous route

Intravenous probably leads to higher insertion failures compared with subcutaneous route (moderate certainty).

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  RR 14.79 [2.87, 76.08]
  3 studies · 238 participants
  Moderate

Intravenous vs subcutaneous route

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 96 participants
  Low

Intravenous vs subcutaneous route

Intravenous may leads to higher dislodgement of device compared with subcutaneous route (low certainty).

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  RR 3.78 [1.16, 12.34]
  1 study · 67 participants
  Low

Intravenous vs subcutaneous route

The review found no eligible studies for this question.

• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found